Development of Group B Streptococcal vaccine
NeoStrep is funded by the European Commission FP7 Programme HEALTH
WP6 The management activities of the project will be controlled through WP6.
Provide both strategic and operational management for the project ensuring the successful completion of the project within the timescale and resources provided.
The specific objectives are:
WORK PACKAGE 6